Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Better Incentives Needed For Worsening Fungal Infection Threat

Jun 29 2017

• By Joseph Haas

Fungi-Candida_608236289_1200x675

Related Content

BIO Notebook, Day 3: Lilly Expands R&D Site, Sigilon Raises Cash And CytomX Talks Deal Strategy

Jun 22 2017

Pipeline Update: New Antifungals Sprout In Warmer Regulatory Climate

Sep 28 2015

GAIN Begins (Part 1): FDA Completes Turnaround On Antibiotic R&D

Feb 20 2013

Related Companies

Cidara Therapeutics, Inc.

Scynexis, Inc.

Astellas Pharma, Inc.

Basilea Pharmaceutica Ltd.

Anacor Pharmaceuticals, Inc.

Bausch Health Companies Inc.

Pfizer Inc.

The Medicines Company

Allergan plc

Merck & Co., Inc.

Additional Topics

Business Strategies Regulation Research & Development Infectious Diseases BioPharmaceutical

More from Anti-infective

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window